Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 22,897-22,908 of 23,847
Drug study icon
Active Not RecruitingNCT05415397

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

This study is comparing Celecoxib 400mg with placebo for people with major depression or Inflammation. Participants receive Celecoxib 400mg or placebo and complete study visits and assessments.

In Amsterdam
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Netherlands
Sponsor
Amsterdam UMC, location VUmc
Condition
Depression
Behavioral study icon
CompletedNCT03495375

Treating Impulsivity in Adults With Probiotics

This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Frankfurt
ADHDOtherFrom 18 Years to 65 Years
Countries
Germany, Hungary, Spain
Sponsor
Hospital Vall d'Hebron
Condition
ADHD
Drug study icon
CompletedNCT02519543

Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can work better when mental health difficulties overlap with substance use.

Multiple locations, including Pittsburgh
BipolarityDrugOver 18 Years
Countries
United States, Canada
Sponsor
Cynthia Calkin
Condition
Bipolarity
Drug study icon
CompletedNCT04747314

Treating Negative Affect in Low Back Pain Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chestnut Hill
AnxietyDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Ajay Wasan, MD, Msc
Condition
Anxiety
Behavioral study icon
WithdrawnNCT04341987

Treating Nightmares Among Domiciliary Patients

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
AddictionBehavioralOver 18 Years
Countries
Sponsor
Canandaigua VA Medical Center
Condition
Addiction
Drug study icon
SuspendedNCT05360953

Treating Nightmares in PTSD With Clonidine and Doxazosin

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tübingen
PTSDDrugFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.